Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORD-I: AA4500 in Dupuytren's Contracture
NCT00528606Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Aug 2007
- Primary completion
- Apr 2008
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Dupuytren's contracture comparing AA4500 with Placebo (2 arms). Primary endpoint: Clinical Success (Reduction in Contracture to 5° or Less) of the Primary Joint After the Last Injection. Started Aug 2007; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on NCT00528606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528606.